Developing and launching new biopharma treatments is costly and risky, with 88% of new molecular entities failing FDA approval. To maximize commercial success, companies need data-driven strategies informed by real-world data and analytics. Definitive Healthcare provides insights into total addressable markets, sales strategies, expert identification, and referral patterns. Their platform helps identify key opinion leaders (KOLs), optimize clinical trial sites, and target high-impact providers. By leveraging claims data and affiliation insights, biopharma companies can make smarter commercialization decisions, reduce risks, and accelerate time to market for promising pipeline assets.

Join for free to read